PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,301,759
|
increas express squamous cell carcinoma antigen mycosi fungoid szari syndrom squamous cell carcinoma antigen scca origin isol tumour specif antigen uterin cervix carcinoma compris two similar protein scca scca induc type cytokin interleukin il il involv antigen atop dermat report howev role mycosi fungoid mf szari syndrom ss also link type cytokin remain seen
|
D000951;D009182;D012751;D015843
|
T121;T129;T123;T116;T191
|
36,301,758
|
multist model probabl treatment clinic respons time remain respons patient moder sever psoriasi treat brodalumab ustekinumab amagin studi relat chang psoriasi area sever index pasi use outcom psoriasi clinic trial limit analys long term data routin practic absolut pasi may clinic use
|
D011565;D000069549
|
T129;T047;T121;T116
|
36,301,757
|
dermoscop chang extrafaci situ invas lentigin melanoma diagnosi non facial melanoma sun damag skin extrafaci lentigo maligna challeng
|
D018327;D008545;D012878
|
T191
|
36,301,756
|
prospect evalu intens puls light treatment meibomian gland dysfunct blephar due ocular rosacea ocular rosacea common skin condit lead dri eye difficult manag
|
D000080343;D001762;D012393
|
T047
|
36,301,755
|
role skin dysbiosi atop dermat cutan microbiota contribut skin barrier function ensur effect protect pathogen contribut mainten epiderm integr dysbiosi frequent present atop dermat ad chronic inflammatori diseas associ skin barrier defect dysbiosi associ reduc bacteri divers mark staphylococcus aureus colon favour case certain local ad specif properti reduc skin acid eas bacteri adhes decreas antimicrobi peptid product furthermor aureus associ skin dysbiosi via product staphylococc virul factor may also particip immunopatholog ad alter epiderm barrier induc inflammatori respons howev current argument recommend screen treatment aureus associ dysbiosi outsid set cutan superinfect nonetheless modul skin microbiota may hold promis ad manag describ relationship exist skin microbiota ad
|
D003876;D064806;D012867
|
T022;T047;T046
|
36,301,754
|
establish mous model netherton syndrom base crisprca technolog netherton syndrom rare sever autosom recess disord domin impair skin barrier function caus mutat spink serin proteas inhibitor kazal type gene encod lekti lymphoepitheli kazal type relat inhibitor
|
D003872;D056770
|
T047
|
36,301,752
|
improv head neck symptom patient atop dermat treat baricitinib base five phase iii clinic trial adult atop dermat ad head andor neck involv frequent bothersom impact qualiti life howev long term topic corticosteroid tcs contraind difficult treat region baricitinib oral select revers inhibitor janus kinas demonstr efficaci adult patient moder sever ad
|
D003876;D001384;D003879
|
T121;T047;T109
|
36,301,750
|
adapalenebenzoyl peroxid gel acn vulgari acn vulgari typic treat combin topic retinoid plus antimicrobi agent recommend nation intern evid base guidelin around globe adapalen synthet topic retinoid avail two concentr daili fix dose combin benzoyl peroxid bpo adapalen bpo approv use moder sever acn proven efficaci good safeti toler across spectrum patient variabl differ age gender skin type diseas sever patient experi issu transient toler retinoid bpo therapi clinic experi good patient educ set expect provid strategi minim irrit overcom major issu articl review data support use adapalen practic includ complementari mechan action adapalen bpo clinic data rang set key aspect patient educ
|
D003879;D000152
|
T121;T047
|
36,301,749
|
patient hereditari angioedema treatment pattern germani delphi consensus studi littl known mani patient hereditari angioedema due c inhibitor defici hae c inh receiv demand andor prophylact treatment clinic featur estim use delphi base consensus preval treatment pattern germani well patient featur link long term prophylaxi
|
D054179
|
T047
|
36,301,748
|
clinic manifest comorbid pemphigus retrospect case control studi southern finland pemphigus associ sever autoimmun dermatolog psychiatr diseas previous studi report increas incid pemphigus finland particular pemphigus foliaceus erythematosus
|
D010392;D003876
|
T047
|
36,301,747
|
dermatolog medic law effect legal issu treatment patient dermatolog practic southern germani usag modern therapi treatment chronic dermatolog diseas proven effect associ high cost high therapi cost might rais legal issu even lead recours claim
|
D003880;D012871;D011565
|
T047;T091
|
36,301,746
|
note field dispens oral antivir drug treatment covid zip code level social vulner unit state decemb august equit access covid therapeut critic aspect distribut program led us depart health human servic hhs two oral antivir product nirmatrelvirritonavir paxlovid molnupiravir lagevrio receiv emerg use author eua food drug administr fda decemb reduc risk covid associ hospit death patient mild moder covid higher risk sever ill hhs distribut medic cost recipi sinc author data collect provid site decemb may indic substanti dispar popul adjust dispens rate high social vulner high vulner zip code compar medium low vulner zip code specif dispens rate week period april may per resid overal popul adjust dispens rate high vulner zip code compar medium vulner low vulner zip code report provid updat analysi dispens rate zip code level social vulner highlight import intervent strategi
|
D000086382
|
T047;T067
|
36,301,744
|
success right hepatectomi recurr liver tumor origin inferior vena cava leiomyosarcoma follow case report background leiomyosarcoma lms inferior vena cava ivc rare malign complet resect may provid better patient surviv hepatectomi intrahepat tumor recurr previous report case report year old woman underw resect ivc lms en bloc nephrectomi adrenalectomi retroperiton soft tissu resect without ivc reconstruct year month ago twenti nine month primari oper solitari intrahepat liver tumor found adjac right middl hepat vein imag follow patient diagnos lms recurr liver function paramet permit major hepatectomi right hepatectomi combin resect vena cava wall leav tumor free margin secur confluenc middl hepat vein success accomplish via anterior approach without advers event intrahepat metastasi lms invad vena cava wall diagnos histor postop cours unev year follow second surgeri observ tumor relaps without adjuv treatment previous report shown ivc lms often observ oper risk prognosi base extens lms toward hepat vein cardiac atrium conclus radic hepatectomi recurr ivc lms previous report case experi reveal challeng surgic intervent result complet tumor remov provid good surviv outcom
|
D007890;D019043;D006528;D008113
|
T191
|
36,301,741
|
receipt first second dose jynneo vaccin prevent monkeypox unit state may octob vaccin jynneo vaccin modifi vaccinia ankara vaccin bavarian nordic prevent monkeypox commenc short confirm first monkeypox case current outbreak unit state may date case report across state district columbia dc puerto rico jynneo vaccin licens food drug administr fda ml dose seri administ subcutan day apart prevent smallpox monkeypox infect found provid protect monkeypox infect current outbreak us depart health human servic hhs alloc million vial jynneo vaccin strateg nation stockpil dose alloc jurisdict base case count estim size popul risk howev initi vaccin suppli sever constrain relat vaccin demand expand outbreak jurisdict highest incid respond priorit first dose administr may juli fda emerg use author eua ml dose intraderm administr jynneo person age year august substanti expand avail vaccin suppli us vaccin strategi focus primarili person known presum exposur monkeypox high risk occup exposur data monkeypox vaccin dose administ report cdc us jurisdict analyz assess vaccin administr complet dose seri total dose jynneo vaccin administ report cdc us jurisdict may octob among person receiv dose non hispan white white hispan latino hispan non hispan black african american black percentag vaccin recipi black hispan may june increas respect juli octob among person receiv first dose elig second dose studi period receiv second dose second dose receipt highest among older adult white person resid south us census bureau region track address dispar vaccin reduc inequ equit access accept vaccin essenti factor plan vaccin program event strategi receipt first second dose necessari optim protect monkeypox virus infect
|
D045908;D012900;D014615;D014612
|
T129;T047;T121;T116
|
36,301,739
|
mitig immunogen aav mediat gene therapi immunosuppress phosphoserin contain zwitterion peptid although recombin adeno associ virus aav consid low immunogen safe gene deliveri immunogen capsid still repres major obstacl readministr aav vector design immunosuppress zwitterion phosphoserin ps contain polypeptid induc aav specif immun toler erad immunolog respons aav modifi zwitterion ps polypeptid maintain transduct activ tissu tropism suppress induct aav specif antibodi hemophilia mous model fviii knockout mice readministr zwitterion ps polypeptid modifi aav fviii vector success evad immunolog respons correct blood fviii level stop blood loss tail bleed experi potent safe technolog mimic natur toler apoptot cell control immunosuppress zwitterion degrad polypeptid precis reduc concern toxic upon readministr work present new concept platform engin viral vector chemic link immunosuppress materi aav vector enabl readministr aav vector maintain transduct effici consider degre
|
D000229;D015316
|
T061;T005
|
36,301,738
|
racial ethnic dispar outpati treatment covid unit state januari juli decemb earli four medic receiv emerg use author eua food drug administr outpati treatment mild moder covid patient high risk progress sever diseas includ nirmatrelvirritonavir paxlovid molnupiravir lagevrio oral antivir expand use remdesivir vekluri intraven antivir bebtelovimab monoclon antibodi mab report document dispar mab treatment race ethnic oral antivir treatment zip code level social vulner howev limit data avail racial ethnic dispar oral antivir treatment use electron health record ehr data covid patient age year sought medic care januari juli treatment paxlovid lagevrio vekluri mab assess race ethnic overal among high risk patient group percentag covid patient seek medic care treat paxlovid increas januari april juli three medic use less frequent juli april juli paxlovid use highest compar white patient black african american black patient prescrib paxlovid less often multipl race patient less often american indian alaska nativ nativ hawaiian pacif island aiannhopi patient less often asian patient less often hispan patient prescrib paxlovid less often non hispan patient racial ethnic dispar paxlovid treatment general somewhat higher among patient high risk sever covid includ age year immunocompromis expans program focus equit awar access outpati covid treatment well covid vaccin includ updat bival booster dose help protect person risk sever ill facilit equit health outcom
|
D005006;D000086382
|
T047;T098;T102;T067
|
36,301,736
|
mass spectrometri imag strategi situ quantif soot size segreg air sampl soot main deriv incomplet combust fossil fuel biomass exist ubiquit differ environment matrix studi detriment effect soot climat air qualiti human health accur quantif soot import prerequisit howev quantif soot environment media especi carbonac media still challeng report matrix free laser desorptionion mass spectrometri ldi ms method situ imag soot particl size segreg aerosol sampl collect filter membran seri round shape sampl spot filter membran select subject ms imag analysi enabl direct situ quantif soot without solvent extract separ especi ms imag serial sampl spot overcom problem sweet spot ldi ms inhomogen distribut soot filter membran thus great improv precis quantif limit detect soot ngm recoveri use method found higher soot content present larger size particul matter smaller size particl suggest aerosol soot main deriv primari emiss sourc furthermor method also show potenti analyz nitrat sulfat speci pm best knowledg first method capabl simultan analysi inorgan salt soot air sampl repres novel strategi situ quantif aerosol soot advantag high specif high sensit separ solvent matrix free
|
D053260;D000393
|
T121;T196;T130;T131
|
36,301,734
|
microbuckl mechano electrochem harvest fiber self power organ motion sensor mechan harvest attract tremend attent self power strain sensor previous harvest requir high stress stretch fiber high young modulus low elast report mechano electrochem harvest mech fiber base new buckl structur low young modulus mpa high elast similar physiolog fluid mech convert mechan energi electr energi chang capacit due chang surfac area caus microbuckl surfac damag cell minim soft fiber stitch tissu pig stomach maintain perform like sutur fiber addit fiber success oper organ similar system compos stomach bladder pig fiber high potenti appli wearabl energi sourc self power strain sensor
|
D000075530;D000076251
|
T033;T073
|
36,301,733
|
influenza incid vaccin effect southern hemispher influenza season chile covid pandem affect influenza virus transmiss histor low activ atyp time alter durat influenza season communiti mitig measur implement sinc includ physic distanc face mask use part credit low influenza detect global pandem compar prepandem season reduc popul exposur natur influenza infect relax communiti mitig measur introduct covid vaccin could increas possibl sever influenza epidem partner chile unit state assess southern hemispher influenza activ estim age group specif rate influenza attribut hospit vaccin effect chile chile recent influenza season began januari earlier prepandem season associ predomin influenza hn virus clade caba cumul incid influenza attribut pneumonia influenza p hospit per person year higher lower incid influenza season adjust influenza hn associ hospit find indic influenza activ continu disrupt emerg sar cov northern hemispher countri might benefit prepar atyp influenza season could includ earli influenza activ potenti sever diseas season especi absenc prevent measur includ vaccin health author encourag elig person seek influenza vaccin take precaut reduc transmiss influenza eg avoid close contact person ill
|
D007251;D000086382;D007252;D009980
|
T129;T121;T067;T109;T005;T047
|
36,301,726
|
human cardiomyocyt suscept irrevers electropor puls electr field human esophag cell puls electr field base pef ablat techniqu wherebi short high intens electr field induc irrevers electropor ire appli various tissu implement standard vitro model compar effect biphas symmetr puls puls phase durat hz puls repetit rate f use two differ human cellular model human induc pluripot stem cell deriv cardiomyocyt hipsc cms human esophag smooth muscl cell hesmc cultur monolay format report pef induc irrevers electropor cell monolay area correspond electr field threshold eft cardiac esophag cultur result suggest mark cell type specif eft estim time lower hipsc cms hesmc subject ident pef treatment eg vs kvcm treatment puls f hz vs kvcm treatment puls f hz pef treatment result increas temperatur around stimul electrod lead unanticip thermal tissu damag proport peak temperatur rise durat pef induc elev temperatur studi temperatur increas rang less c high c howev temperatur chang transient quick return baselin highest observ return maximum record temperatur ten second
|
D018274;D032383
|
T059;T025
|
36,301,720
|
aortic waveform respons insulin late versus earli chronotyp metabol syndrom late chronotyp lc correl reduc metabol insulin sensit cardiovascular diseas unclear insulin action aortic waveform inflamm alter lc versus earli chronotyp ec adult metabol syndrom n met classifi either ec morn evening questionnair meq lc meq min euglycem clamp mum min mgdl indirect calorimetri use determin metabol insulin sensit glucos infus rate gir nonoxid glucos dispos nogd aortic waveform via applan tonometri inflamm blood biochemistri assess min clamp lc higher fat free mass lower vo max gir nogd group p ec despit differ min waveform group insulin stimul elev puls pressur amplif reduc aix augment pressur ap time effect p howev ec decreas forward pressur pf interact effect p insulin versus rise lc although lc higher tumor necrosi factor tnf group effect p ec lc ec insulin stimul increas tnf decreas hs crp time effect p higher meq score relat greater insulin stimul reduct ap r p pf r p vo max correl insulin mediat reduct aix r p lt ap r p lt nogd relat decreas ap r p pf r p insulin infus lc depict blunt forward pressur waveform respons insulin higher tnf met work need assess endotheli function across chronotyp
|
D007333;D024821;D006946
|
T047;T046
|
36,301,719
|
determin tempor dose composit effect nutrit substrat vitro model intrahepatocellular triglycerid accumul patholog accumul intrahepat triglycerid underpin earli stage nonalcohol fatti liver diseas nafld progress fibrosi cirrhosi cancer liver studi human suggest consumpt diet enrich satur compar unsatur fatti acid fas detriment liver fat accumul metabol howev reason diverg remain unclear physiolog relev cellular model requir therefor aim studi investig effect modifi media composit concentr treatment frequenc sugar fas insulin intrahepatocellular triglycerid content intracellular glucos fa circadian function huh cell treat human serum combin sugar fas low fat low sugar lfls high fat low sugar hfls high fat high sugar hfhs enrich either unsatur opla satur pola fas day daili altern treatment regim stabl isotop tracer util investig basal andor insulin respons chang hepatocyt metabol respons differ treatment regim cell viabil media biochemistri intracellular metabol circadian biolog quantifi fa composit media opla vs pola influenc cell viabil intracellular triglycerid content hepatocyt contrast pola treat cell lower fa oxid media acet higher fa concentr display lower intracellular glycogen content diminish insulin stimul glycogenesi compar opla treat cell addit hfhs also profound effect circadian oscil gene express cell treat daili hfhs least day result cellular model display characterist earli stage nafld seen human repeat treatment longer durat day may provid opportun investig lipid glucos metabol sever stage nafld
|
D065626
|
T047
|
36,301,712
|
hydroxyl rich hydrophil endocytosi promot peptid posit charg deliv cargo molecul across plasma membran critic biomed research need develop molecular well defin tag enabl cargo transport ever increas report hydrophil endocytosi promot peptid epp rich hydroxyl group posit charg epp transport wide array small molecul cargo divers panel anim cell mechanist studi reveal enter cell caveolin dynamin depend endocytosi pathway mediat surfac receptor fibrinogen c domain contain protein endocytosi epp traffick earli late endosom within min time epp partit among cytosol lysosom long live compart also demonstr promin transcytosi abil vitro vivo model studi prove posit charg indispens featur hydrophil cell penetr peptid provid new categori molecular well defin deliveri tag biomed applic
|
D004705;D057846
|
T116;T043
|
36,301,706
|
bacteri collagen templat synthesi assembl inorgan particl collagen use common templat miner assembl inorgan particl special arrang fibril presenc charg residu streptococc bacteri collagen inher secret surfac streptococcus pyogen progress use altern type anim collagen bacteri collagen rich charg amino acid act substrat nucleat growth inorgan particl show bacteri collagen use nucleat three differ inorgan materi hydroxyapatit crystal silver nanoparticl silica nanoparticl collagenminer composit show even distribut inorgan particl along collagen fiber particl homogen size compar miner form absenc collagen scaffold furthermor gelat silica occur miner repres mean produc process self stand collagen composit challeng achiev bacteri collagen alon overal highlight advantag simpli combin bacteri collagen miner expand applic field biomateri tissu engin especi bone regen scaffold
|
D053768
|
T073
|
36,301,704
|
effect bifidobacterium lacti hn lactobacillus acidophilus ncfm volatil sulfur compound produc oral anaerob halitosi term refer unpleas foul odor origin oral caviti main caus volatil sulfur compound vscs produc oral anaerob porphyromona gingivali fusobacterium nucleatum treponema denticola prevotella intermedia general therapi tooth tongu brush usag bacteriostat hard provid harmless continu therapeut effect halitosi recent evid suggest potenti clinic applic valu probiot treatment halitosi studi bifidobacterium lacti hn lactobacillus acidophilus ncfm identifi four kind probiot antimicrobi activ pathogen relat halitosi inhibitori effect vscs investig result show b lacti hn l acidophilus ncfm exhibit superior bacteriostat action pathogen relat halitosi show remark inhibitori effect product emiss vscs find suggest b lacti hn l acidophilus ncfm may serv promis part success halitosi manag plan
|
D013457;D006209
|
T104;T184
|
36,301,701
|
modul earli stage neuron outgrowth plane graphen correct wire neural network requir neuron integr incred repertoir cue found extracellular environ astonish effici process play pivot role correct wire brain develop axon regener biolog inspir micro nanostructur substrat shown regul axon outgrowth parallel sever studi investig graphen potenti conduct neural interfac abl enhanc cell adhes neurit sprout outgrowth engin singl layer fuzzi graphen morpholog dfg dfg collaps si nanowir sinw mesh templat nt dfgc dfg noncollaps sinw mesh templat nt dfgnc neural instruct materi micrometr protrud featur nws templat dictat neuron growth cone establish well influenc axon elong branch furthermor neuron graphen coupl investig comprehens view integrin mediat contact adhes point plasma membran curvatur process
|
D001369;D006108
|
T026;T196;T109
|
36,301,699
|
textur transform super resolut low dose comput tomographi comput tomographi ct wide use diagnos mani diseas low dose ct activ pursu lower ioniz radiat risk relat smoother kernel typic use low dose ct suppress imag nois may sacrific spatial resolut work propos textur transform network simultan reduc imag nois improv spatial resolut ct imag network refer textur transform super resolut ttsr refer base deep learn imag super resolut method built upon generat adversari network gan noisi low resolut ct lrct imag routin dose high resolut hrct imag sever queri key transform respect imag translat optim deep neural network dnn textur extract correl embed attent base textur transfer synthesi achiev joint featur learn lrct hrct imag super resolut ct srct imag evalu srct perform use data simul xcat phantom program real patient data peak signal nois ratio psnr structur similar index measur ssim featur similar fsim index use quantit metric comparison srct perform cubic spline interpol srgan gan super resolut addit content loss gan circl gan super resolut cycl consist use compar two method ttsr restor detail srct imag achiev better psnr ssim fsim simul real patient data addit show ttsr yield better imag qualiti demand much less comput time high resolut low dose ct imag denois block match filter bmd gan circl summari propos ttsr method base textur transform attent mechan provid effect effici tool improv spatial resolut suppress nois low dose ct imag
|
D007091;D014057
|
T060;T066
|
36,301,687
|
water dimer driven dna base superstructur mismatch hydrogen bond exist water dimer equilibrium water vapor room temperatur anomal properti reveal recent studi suggest benchmark role water dimer experi theori howev limit observ individu water dimer due challeng water separ generat singl molecul level achiev real space imag individu confin water dimer embed insid self assembl layer dna base adenin ag hydrat adenin layer water dimer caus local surfac chiral invers way neighbor homochir adenin molecul becom heterochir hydrat result mismatch hydrogen bond pattern neighbor adenin molecul furthermor mutual influenc adenin superstructur dynam confin water dimer corrobor theoret simul calcul observ singl confin water dimer offer unpreced approach studi fundament form water cluster interact local chemic environ
|
D004247;D000225
|
T123;T114
|
36,301,683
|
deriv causal relationship rest state function connect use ssfo base optogenet fmri object brain network extens studi collect brain region function inter connect howev studi causal relationship brain wide function connect critic brain function remain challeng aim examin feasibl use ssfo base optogenet function magnet reson imag infer causal relationship ie direct inform brain network approach combin ssfo base optogenet fmri rest state rodent model studi local increas excit affect brain wide neural activ rest state function connect rsfc incorpor pearson correl partial correl analys graphic model deriv direct inform connect exhibit rsfc modul main result dentat gyrus dg sensit ssfo activ found signific chang activ connect sever brain region associ dg particular medial prefront cortex causal infer result show accuraci rate compar direct inform base anatom trace data signific studi establish system investig relationship local region activ rsfc modul provid way analyz under causal relationship brain region
|
D008279;D001931
|
T060;T062;T170;T059
|
36,301,663
|
case drug induc steven johnson syndrom steven johnson syndrom rare consequenti often life threaten disord often drug induc
|
D013262
|
T047
|
36,301,662
|
medic hiccup chlorpromazin induc agranulocytosi year old male agranulocytosi sever decreas absenc neutrophil side effect sever medic includ chlorpromazin prompt recogn lead overwhelm infect sepsi death
|
D006606;D000380;D018805
|
T033;T047;T046
|
36,301,661
|
hyponatremia associ standard dose trimethoprim sulfamethoxazol use immunocompet patient trimethoprim sulfamethoxazol tmp smx use immunocompromis patient caus dose depend electrolyt irregular includ hyponatremia hyperkalemia metabol acidosi report case isol hyponatremia caus low dose tmp smx use immunocompet patient mimick syndrom inappropri antidiuret hormon secret siadh
|
D007010;D006947
|
T033;T047
|
36,301,660
|
rare case acn medic induc drug reaction eosinophilia system symptom acn vulgari common skin condit late adolesc frequent requir system treatment antibiot androgen receptor blocker moderateto sever case
|
D007010;D063926;D000152
|
T047
|
36,301,659
|
case report covid mrna vaccin associ myocard present case report highlight singl patient develop myocard within day receiv pfizer moderna covid mrna vaccin
|
D000086382;D000086663;D009205
|
T200;T047;T067
|
36,301,658
|
acut worsen atyp parkinson syndrom receiv second dose moderna covid vaccin atyp parkinson syndrom rare set neurodegen condit patient experi typic symptom parkinson diseas addit various unrel issu
|
D000086382;D000086663;D010300
|
T200;T047;T067
|
36,301,657
|
encephalopathi akinet mutism child covid infect case report covid associ neurolog complic includ encephalopathi akinet mutism
|
D000405;D000086382
|
T047;T067
|
36,301,656
|
sever matern morbid neonat mortal covid infect case report matern coagulopathi advers fetal effect possibl result covid infect pregnanc case demonstr potenti fatal outcom occur simultan
|
D000086382
|
T047;T067
|
36,301,655
|
posttraumat stress disord physician assist work icu covid present case report physician assist experi posttraumat stress disord ptsd provid care patient affect covid believ case import reveal unfortun impact covid mental health health care profession
|
D000086382;D013313;D010823
|
T047;T097;T067;T048
|
36,301,654
|
day discharg robot hysterectomi resourc util qualiti improv project implement low cost educ initi improv rate day discharg follow hysterectomi perform malign assess feasibl impact resourc util
|
D065287;D010535
|
T061;T060
|
36,301,653
|
safe opioid prescrib pediatr patient interprofession learn activ innov onlin cours safe opioid prescrib pediatr patient design interprofession team expert interprofession target audienc clinician wisconsin
|
D007400;D000701
|
T121;T131;T054;T109
|
36,301,652
|
implement activ screen program sar cov experi academ medic center studi document experi academ medic center implement sar cov screen asymptomat research personnel support return work initi donor cadav support person student educ
|
D012367;D000086382
|
T047;T067;T114
|
36,301,651
|
wisconsin covid safer home order perspect pain stress function pediatr patient chronic pain given enforc quarantin associ psycholog distress object understand factor either help harm pediatr chronic pain patient wisconsin safer home quarantin
|
D059350;D000086382
|
T184;T047;T067
|
36,301,650
|
use health care communiti base servic peopl live dementia caregiv covid pandem peopl live dementia particular affect covid pandem
|
D000086382;D003704
|
T047;T067;T048
|
36,301,649
|
interdisciplinari deprescrib aspirin prescrib educ provis patient specif recommend inappropri aspirin use lead increas frequenc bleed event poor patient outcom
|
D001241;D000069340
|
T121;T058;T170;T109
|
36,301,648
|
difficult question mani gray area nuanc abort attitud among physician abort polar social medic issu even among physician though public may expect physician hold pure scientif attitud abort attitud behavior strong inform social polit factor public recent survey studi physician academ medic center abort attitud report strong support abort access howev unwil consult abort relat case mani perceiv littl profession connect abort retic public advoc posit
|
D000028;D010820
|
T061;T093;T033;T097;T081;T046
|
36,301,647
|
leverag social determin health reduc hospit length stay pilot qi project solid tumor oncolog patient covid pandem impact social determin health sdoh hospit cancer patient hospit length stay unknown institut hospit wide sdoh survey examin patient specif barrier various domain sdoh facilit hospit discharg integr electron medic record studi report effect sdoh survey length stay oncolog patient outpati referr generat facilit discharg
|
D000086382;D009369
|
T047;T191;T067
|
36,301,646
|
perinat outcom associ institut chang earli covid pandem mani institut implement polici chang protect patient clinician covid pandem studi examin institut polici chang patient behavior affect perinat outcom hypothes obstetr practic chang occur chang affect perinat outcom
|
D007751;D000086382
|
T061;T047;T067
|
36,301,645
|
chang pediatr intens care admiss wisconsin covid pandem perceiv chang frequenc reason admiss wisconsin pediatr intens care unit picu advent covid pandem hypothes rate total schedul respiratori viral admiss lower first calendar year pandem would predict histor admiss data find would reflect import chang picu util paradigm pandem descript picu admiss chang singl american state pandem
|
D000086382
|
T047;T067
|
36,301,644
|
analysi emerg depart patient visit volum academ health system covid pandem statewid safer home order describ patient visit volum patient acuiti demograph academ health system emerg depart ed implement covid pandem safer home order
|
D000086382
|
T047;T067
|
36,301,643
|
patient view primari care telemedicin covid pandem implic futur integr multimethod studi telemedicin becom integr part primari care sinc covid pandem paper report patient assess earli telemedicin visit
|
D000086382;D017216
|
T047;T058;T067
|
36,301,642
|
sharp rise new onset pediatr diabet covid pandem recent studi report signific impact covid pandem incid sever manag diabet
|
D000086382;D003924
|
T047;T067
|
36,301,613
|
barrier facilit use ehealth support gestat diabet mellitus self manag systemat literatur review percept health care profession women gestat diabet mellitus gestat diabet mellitus gdm one common medic complic pregnanc ehealth technolog prove success support self manag medic condit digit technolog potenti improv gdm self manag
|
D016640;D017216;D000073278
|
T047;T058
|
36,301,612
|
diagnosi clinic signific human bocavirus children hospit lower acut respiratori infect molecular detect respiratori secret serum introduct human bocavirus hbov infect occur viral genom presenc respiratori secret rs serum therefor sampl use diagnosi gap statement diagnost sensit hbov dna detect serum durat dnaaemia sever clinic case elucid aim determin hbov dna serum rs paediatr patient hospit lower acut respiratori infect lari analys clinic epidemiolog featur posit case methodolog prospect transvers studi physician select clinic situat obtain pair clinic sampl rs serum test pcrqpcr hbov posit case analys consid time specimen collect co detect clinic manifest viral load statist signific level set result hbov detect case includ patient virus detect serum rs p posit rate signific differ patient rs serum collect within beyond h admiss singl hbov infect identifi patient three patient hbov clinic sampl rs clinic sampl within h admiss cough p rhiniti p signific frequent among patient diagnos bronchiol pneumonia frequent compar case co infect p signific differ identifi among patient high medium low viral load hbov regard rate posit clinic sampl time collect rs serum co detect first episod lari clinic manifest comorbid requir assist ventil intens care unit icu patient signific higher frequenc detect p co detect p compar patient standard care conclus hbov preval among infant patient hospit lari includ standard test add aetiolog diagnosi case especi patient admit icu hbov detect serum contribut signific diagnosi compar detect respiratori secret
|
D056661;D010322;D012141
|
T005;T047
|
36,301,611
|
compar vitro activ omadacyclin eravacyclin tigecyclin non esbl produc esbl produc carbapenem resist isol k pneumonia introduct extend spectrum lactamas esbl produc enterobacteriacea carbapenem resist enterobacteriacea character world health organ pathogen new antibiot urgent need omadacyclin eravacyclin two novel antibacteri within tetracyclin class gap statement limit data regard comparison activ omadacyclin eravacyclin tigecyclin k pneumonia isol differ antimicrobi suscept profil aim object compar vitro activ omadacyclin eravacyclin tigecyclin collect k pneumonia isol includ non esbl produc esbl produc carbapenem resist strain methodolog nineti four k pneumonia isol includ non esbl produc esbl produc carbapenem resist carri bla oxa carri bla ndm strain includ studi esbl carbapenemas gene detect convent pcr omadacyclin eravacyclin tigecyclin mic determin gradient diffus method interpret use us food drug administr fda defin breakpoint result overal percentag tigecyclin suscept strain higher percentag omadacylin suscept eravacyclin suscept strain omadacyclin eravacyclin suscept rate among non esbl produc isol among esbl produc isol common esbl gene detect blactx follow bla tem bla shv omadacyclin eravacyclin suscept rate among isol carri bla tem wherea among isol carri bla tem omadacyclin eravacyclin suscept rate among carbapenem resist isol respect omadacyclin suscept rate among bla oxa posit bla ndm posit isol respect eravacyclin suscept rate among bla oxa posit bla ndm posit isol respect one carbapenem resist isol intermedi one esbl produc isol resist tigecyclin conclus overal tigecyclin activ tetracyclin isol omadacyclin eravacyclin show excel activ esbl produc k pneumonia isol carri bla tem omadacyclin show reason activ carbapenem resist k pneumonia isol carri bla oxa bla ndm
|
D015780;D004926
|
T007;T195;T109
|
36,301,610
|
compar genom pangenom vancomycin resist suscept enterococcus faecium irish hospit introduct enterococcus faecium emerg import nosocomi pathogen increas difficult treat due genet acquisit vancomycin resist ireland recalcitr vancomycin resist bloodstream infect rate compar develop countri hypothesisgap statement vancomycin resist rate persist amongst e faecium isol irish hospit evolutionari genom govern trend fulli elucid methodolog set vancomycin resist isol sequenc construct dataset alongsid public avail irish genom dataset extens analys use silico methodolog compar genom pangenom phylogenet genotyp compar function analys uncov distinct evolutionari coevolutionari clinic relev popul trend result result suggest stabl term genom size gc number gene yet genet divers popul term gene content e faecium persist ireland acquir resist aris via plasmid acquisit vana lesser extent chromosom recombin vanb popul analysi reveal five cluster one cluster partit four clade transcend isol date pangenom recombin analys reveal open whole genom chromosom specif pangenom illustr rampant evolutionari pattern compar resistom virulom uncov distinct chromosom mobilom propens multidrug resist widespread chromosom point mutat mediat resist chromosom harbour arsenal virul factor interest potenti differ biofilm format strategi highlight coevolutionari analysi suggest differenti biofilm genotyp vana vanb isol conclus result highlight evolutionari histori irish e faecium isol may provid insight under infect dynam clinic set due appar eas vancomycin resist acquisit time suscept e faecium concurr reduc irish hospit mitig potenti resist infect
|
D016984;D016908;D065507
|
T047;T007
|
36,301,609
|
mgpb genotyp genet divers antimicrobi resist mycoplasma genitalium introduct antimicrobi resist amr among mycoplasma genitalium global issu understand transmiss dynam infect import factor reduc occurr amr hypothesisgap statement limit inform genotyp amr trait genitalium aim singl locus sequenc base slsb mgpb sequenc type genet divers analys amr genitalium isol patient republ korea perform clarifi transmiss dynam elud proper manag methodolog sanger sequenc mgpb rrna parc gyra gene total genitalium posit specimen patient carri result twenti seven differ mgpb genotyp gts identifi report previous gt gt occur frequent n n respect genet divers amr determin site random dispers among differ gts howev gts classifi two phylogenet distinct cluster signific correl patient age genet divers posit rrna gene gts consecut sampl patient compar investig tempor chang gts one specimen chang gt follow suggest new infect conclus mgpb sequenc type reliabl tool epidemiolog studi two cluster differ characterist term genet divers cluster genet divers amr determin site may explain high preval specimen subsequ antimicrobi exposur studi period
|
D045704;D009175
|
T047;T007
|
36,301,607
|
retrospect cross section observ studi sar cov reinfect la ribera health depart valencia spain introduct possibl reinfect sever acut respiratori syndrom coronavirus sar cov wide proven fact may clinic implic hypothesi gap statement known whether case reinfect sar cov la ribera health depart aim determin whether case reinfect sar cov la ribera health depart identifi characterist methodolog retrospect cross section observ studi case reinfect sar cov popul la ribera depart march februari posit baselin cohort includ case posit rt pcr sar cov reinfect case resolut first episod accord world health organ criteria present new posit rt pcr result result total case posit rt pcr consid reinfect meant cumul incid incid densiti case per person day case occur highest incid peak pandem depart seventi five per cent patient case older year healthcar profession nurs home resid immunosuppress comorbid sever critic death case reinfect episod respect first episod tendenc milder requir fewer day hospit rt pcr becam negat earlier develop greater humor respons sick leav period shorter median period rt pcr first episod rt pcr second episod day rang iqr conclus sar cov reinfect case rare tend mild occur within median period day
|
D000086402;D000086382
|
T005;T067;T047
|
36,301,602
|
current status telemedicin technolog use across world health organ european region overview systemat review sever systemat review evalu use telemedicin clinician patient health author improv deliveri care member state world health organ european region conduct recent year howev studi summar find review conduct
|
D017216
|
T058
|
36,301,597
|
viral aetiolog acut central nervous system infect children iran introduct viral infect increas import caus central nervous system cns complic hypothesisgap statement comprehens insight cns infect due viral agent among iranian children aim studi aim investig viral aetiolog clinic epidemiolog profil children acut infect cns methodolog prospect studi conduct children referr hospit isfahan iran june june multiplex pcr assay use detect viral causat agent cerebrospin fluid throatrect swab sampl result among patient elig criteria confirm probabl viral aetiolog detect patient includ enterovirus herp simplex virus hsv epstein barr virus varicella zoster virus vzv influenza virus hn mump higher proport pcr posit sampl infant age group enceph meningoenceph diagnos pcr posit case respect conclus find research provid insight clinic viral aetiolog pattern acut cns infect iran import molecular method identifi cns virus hsv vzv identifi import caus enceph young children
|
D020031;D053118;D002494;D004660
|
T047;T005
|
36,301,593
|
rapid fluoroquinolon resist detect pseudomona aeruginosa use mismatch amplif mutat assay base real time pcr background antimicrobi resist amr ever increas global health concern one crucial facet tackl amr epidem earlier accur amr diagnosi particular danger high multi drug resist eskap pathogen pseudomona aeruginosa object aim develop two sybr green base mismatch amplif mutat assay sybr mama target gyra ti gyra gyra dn dy dh gyra togeth variant caus major fluoroquinolon fq amr p aeruginosa method follow assay valid gyra gyra sybr mama test australian clinic p aeruginosa isol demonstr intermediateful ciprofloxacin resist accord antimicrobi suscept test result two sybr mama correct predict amr phenotyp major isol intermediateful fq resist fq sensit strain predict sensit phenotyp whole genom sequenc confirm concord sybr mama genotyp conclus gyra sybr mama provid rapid cost effect method day identif fq amr p aeruginosa addit sybr mama target gyrb sysf variant would increas fq amr predict clinic implement assay permit time treatment alter case decreas fq suscept identifi lead improv patient outcom antimicrobi stewardship
|
D024841;D011550
|
T007;T195;T109
|
36,301,591
|
paracetamol use patient osteoarthr lower back pain infodemiolog studi observ analysi electron medic record data lower back pain lbp osteoarthr oa common musculoskelet disord account around year live disabl worldwid howev lack real world data condit paracetamol brand frequent prescrib franc musculoskelet pain includ dolipran dafalgan ixprim tramadol paracetamol
|
D017116;D010003
|
T184;T047
|
36,301,590
|
effect computer cognit train delay cognit function declin peopl mild cognit impair systemat review meta analysi current cure mild cognit impair mci delay progress could signific reduc diseas burden improv qualiti life patient mci computer cognit train cct recent becom potenti instrument improv cognit howev evid effect remain limit
|
D060825;D003072
|
T048
|
36,301,587
|
transient incomplet separ speci close diffus studi stabil affin complex larg molecul generic separ small one though partial temporarili pressur driven flow insid capillari transient incomplet separ appli speci diffus coeffici differ least order magnitud demonstr first time analyt util transient incomplet separ speci close diffus coeffici first prove silico even small differ diffus lead detect transient incomplet separ speci second use comput simul prove separ use reliabl determin equilibrium dissoci constant k complex compos similar size molecul final demonstr experiment use separ accur determin k valu protein aptam complex conclud accur constant via transient incomplet separ acti serv refer method affin character protein aptam bind solut
|
D019075;D009841
|
T059;T114
|
36,301,570
|
new categori never event end harm hospit polici jama forum discuss hospit polici harm patient aggress collect payment medic bill afford pay provid way address current never event polici
|
D006761;D006278
|
T089;T064;T073;T093
|
36,301,569
|
impact coronavirus diseas protocol primari revis total knee arthroplasti background surgic site infect ssi total knee arthroplasti tka associ increas morbid healthcar expenditur coronavirus diseas covid pandem institut intensifi hygien standard includ greater glove person protect equip ppe mask use assess effect chang ssi rate primari total knee arthroplasti ptka revis total knee arthroplasti rtka patient method retrospect review perform identifi tka januari june singl institut baselin characterist outcom compar januari februari may june covid pandem restrict oper servic place analyz first may novemb second decemb june period full oper servic restor result total ptka pre pandem pandem rtka pre pandem pandem includ primari case superfici deep ssi rate similar covid howev revis tka incid p superfici p ssis decreas covid primari tka longer oper time p shorter length stay los p covid ptka p rtka p discharg skill nurs facil less frequent covid well conclus hospit implement covid motiv hygien protocol superfici ssi rate decreas rtka ptka covid patient less like discharg skill nurs facil ptka oper time increas although chang occur intensifi hygien protocol research need determin factor contribut observ chang
|
D019645;D000086382;D017934
|
T061;T047;T005;T067
|
36,301,553
|
danicopan oral complement factor inhibitor exhibit high sustain exposur ocular tissu preclin studi complement altern pathway ap dysregul implic geograph atrophi advanc form age relat macular degener danicopan investig first class inhibitor factor essenti ap activ enzym assess danicopan distribut posterior segment eye oral dose
|
D057092;D000417
|
T047
|
36,301,549
|
recurr symptom follow day symptom free period patient covid cohort studi us adult untreat covid examin type length symptom experienc follow symptom recurr
|
D000086382
|
T047;T067
|
36,301,548
|
sale iodin contain drug europ follow begin war russia ukrain cross section studi investig sale counter iodin contain drug european countri januari march
|
D003132;D007455
|
T078;T123;T121;T196;T097;T081;T057
|
36,301,547
|
pattern neural function connect infant famili risk development dyslexia development dyslexia herit learn disabl affect general popul detriment impact mental health vocat potenti individu dyslexia show alter function organ languag read neural network howev remain unknown earli life neural network alter might emerg
|
D001931;D004410
|
T062;T060;T048
|
36,301,546
|
effect portabl rent subsidi mentorship socioeconom inclus young peopl exit homeless communiti base pilot random clinic trial publish random clinic trial primari outcom socioeconom inclus young peopl experienc homeless
|
D000086382;D006703
|
T098;T067;T033;T047;T095
|
36,301,545
|
evalu intervent address smoke food insecur preoper surgic clinic appoint health us popul decreas novel strategi need revers trajectori surgic episod may opportun time screen poor health behavior social need yet littl known feasibl accept effort
|
D012907;D016540
|
T055
|
36,301,544
|
newborn cri acoust assess neonat opioid withdraw syndrom use machin learn assess opioid withdraw neonat neonat opioid withdraw syndrom now problemat current assess method base subject observ rate cri distinct compon now assess tool measur object use acoust analysi
|
D009357;D013375
|
T184;T047;T048
|
36,301,543
|
long term outcom transcathet aortic valv replac lotus valv vs corevalveevolutr secondari analysi repris iii random clinic trial long term follow transcathet aortic valv replac tavr interest given longitudin data mortal durabl transcathet heart valv limit repris iii reposition percutan replac stenot aortic valv implant lotus valv system random clinic evalu random clinic trial compar mechan expand lotus valv self expand corevalveevolutr tavr platform
|
D065467;D001024;D013927;D020521
|
T061;T047;T046
|
36,301,542
|
preval correl long covid symptom among us adult persist covid symptom beyond month long covid increas recogn common sequela acut infect
|
D018352;D000086382;D011024
|
T047;T067
|
36,301,541
|
associ covid vaccin intens care unit admiss outcom critic ill patient covid pneumonia lombardi itali data associ covid vaccin intens care unit icu admiss outcom patient sar cov relat pneumonia scarc
|
D000086382;D011014
|
T047;T050;T067
|
36,301,540
|
genom wide investig maximum habitu alcohol intak us veteran relat alcohol consumpt trait alcohol use disord alcohol genom wide associ studi gwass general focus alcohol consumpt alcohol use disord aud examin habitu drink behavior like maximum habitu alcohol intak maxalc
|
D000437;D014728
|
T098;T048
|
36,301,537
|
comorbid matter distress communiti index fail predict mortal necrot soft tissu infect background necrot soft tissu infect nstis life threaten infect requir prompt intervent distress communiti index dci comprehens rank socioeconom well base zip code sought identifi role dci predict mortal nsti remain unknown patient method retrospect singl institut analysi patient diagnos nsti requir surgic intervent dci composit score base communiti level factor unemploy educ level poverti rate median incom busi growth hous vacanc dci score match patient zip code stratif perform use quintil parametr non parametr analys perform evalu demograph clinic characterist multivari regress analys perform identifi independ variabl associ outcom result six hundr twenti patient met inclus criteria nineti day mortal n patient die like femal older median age year bodi mass index bmi higher charlson comorbid index interquartil rang iqr regress analysi neither composit dci quintil individu compon score found correl mortal interest under heart diseas hepat dysfunct renal diseas baselin found signific correl mortal nsti p valu conclus socioeconom status insur payer champion inclus construct risk model evalu resourc util compar hospit determin patient manag sever communiti distress measur dci correl mortal nsti despit contrast evid diseas find like caus combin individu communiti level resourc highlight recognit comorbid correl mortal absenc dci relat associ observ studi warrant investig mechan prevent organ dysfunct
|
D018461;D019115
|
T047
|
36,301,532
|
retin cone mosaic sws mutant medaka oryzia latip teleost ablat short singl cone sscs express short wavelength sensit opsin sws well analyz field regen retin cell contrast ablat studi phenomena caus complet delet sws less well understood assess effect sws defici retin structur establish analyz sws mutant medaka
|
D055355;D009990;D017949
|
T123;T116;T025;T013
|
36,301,531
|
associ age system variabl longitudin trend intraocular pressur larg scale health examin cohort detail effect age system factor intraocular pressur iop fulli understood lack larg scale longitudin investig studi aim investig effect various system factor longitudin chang iop
|
D007429;D009798
|
T047;T042
|
36,301,530
|
foveal cone structur patient blue cone monochromaci blue cone monochromaci bcm rare inherit cone disord long l middl wavelength sensit cone class either impair nonfunct assess genotyp phenotyp relationship bcm improv understand retin develop absenc function l cone examin foveal cone structur patient genet confirm bcm use adapt optic scan light ophthalmoscopi aoslo
|
D003117
|
T047
|
36,301,525
|
tempor dynam face adapt appear face strong affect adapt face seen previous number studi examin time cours aftereffect integr time adapt pool signal control adapt state remain uncertain examin effect tempor frequenc face gender aftereffect induc pair face altern two gender assess aftereffect pool success face versus driven last face seen first experi found tempor frequenc hz fail produc aftereffect suggest fair long integr time second experi therefor probe slower altern rate hz rate hz ie second per face requir generat signific aftereffect last present face consist averag time constant second exponenti decay integr window integr time substanti longer found previous analog effect altern color thus point potenti slower mechan adapt face compar chromat adapt
|
D005366
|
T041
|
36,301,518
|
vapor generat rare earth element via reaction tetrahydrobor chemic ident mechan format technic note report first time simultan vapor generat rare earth element ree via reaction sodium tetrahydrobor thb signific improv ree vapor generat effici discov presenc arsenazo iii ar subsequ critic evalu impact various experiment variabl includ concentr acid thb ar blank limit reagent contamin impur ar detect limit lod rang g l achiev base three time standard deviat method blank propos vapor generat induct coupl plasma mass spectrometri icp ms natur releas ree speci studi various approach identifi ree nanoparticl ree ar chelat dual rout mechan vapor generat ree therebi propos
|
D008674;D053758
|
T196;T073
|
36,301,508
|
hypothalam insulin express remain unalt short term fast femal rat previous studi show h fast increas insulin express hypothalamus male rat therefor want examin phenomenon occur femal rat whether depend estrus cycl phase
|
D005215;D007328
|
T121;T116;T055;T033;T125
|
36,301,450
|
influenc risk protect factor adolesc alcohol cannabi electron cigarett use misus substanc adolesc serious public health concern unit state three use substanc adolesc alcohol cannabi electron cigarett accord social develop model better understand risk protect factor across three substanc assist predict potenti substanc use well strategi prevent purpos current studi examin similar differenti influenc specif set risk protect factor ie favor attitud toward substanc use perceiv risk harm peer substanc use interact prosoci peer parent favor attitud toward substanc use famili manag perceiv avail substanc reward prosoci involv past day alcohol cannabi e cigarett use adolesc present studi base secondari data analysi prevent need assess survey administ everi two year state utah larg sampl student grade grade subsampl student n includ present analysi logist regress use examin predict relat set four risk four protect factor past day use alcohol cannabi e cigarett use general result indic endors four risk factor predict increas use substanc wherea endors four protect factor predict decreas use implic find suggest may similar risk protect factor across alcohol cannabi electron cigarett addit studi add bud literatur risk protect factor associ adolesc e cigarett use
|
D000072137;D066300;D002188;D019966
|
T121;T073;T109;T055;T002;T033;T167;T048
|
36,301,434
|
bruton tyrosin kinas inhibit multipl sclerosi multipl sclerosi ms inflammatori diseas central nervous system cns chronic often progress diseas cours current diseas modifi treatment dmts limit diseas progress primarili dampen immun cell activ peripher blood hinder migrat peripheri cns new therapi need target cns immunopatholog key driver disabl progress ms articl review bruton tyrosin kinas inhibitor btkis new class experiment therapi intens evalu ms focus potenti peripher central mechan action btkis use recent clinic trial ms
|
D000077329;D009103;D047428
|
T121;T047;T126;T116
|
36,301,433
|
featur temperatur adapt phaeodactylum tricornutum nitzschia sp skeletonema costatum bacillariophycea differ light condit two type possibl adapt respons photosynthet apparatus diatom chang growth temperatur condit shown first type temperatur depend chang content chlorophyl cell aim match rate light dark reaction photosynthesi note phaeodactylum tricornutum nitzschia sp limit light intens temperatur decreas c lead increas initi slope light depend cchl ratio optim light condit temperatur decreas c c cchl ratio increas fold speci second type respons chang growth temperatur condit observ skeletonema costatum chlorophyl content cell depend temperatur rang c adapt photosynthet apparatus case probabl occur due chang activ enzym system rate enzym process potenti product studi speci alga c calcul increas biomass per unit chlorophyl per day differ signific condit light inhibit temperatur decreas lead progress decreas content chlorophyl cell algal speci studi due decreas rate pigment synthesi background intens photooxid
|
D017377
|
T204
|
36,301,432
|
endosperm develop trait compar analysi endospermogenesi embryogenesi angiosperm articl discuss fertil process nucleus posit primari cell specif earli endosperm develop principl classif new refin classif propos endosperm develop mode includ three hierarch level type subtyp variat two type distinguish morphogenet potenti micropylar chalaz primari cell cellular karyokinesi complet cytokinesi cell helobi karyokinesi take place cell chalaz cell sometim remain mononucl nuclear endosperm consid subtyp helobi type subtyp isol extent micropylar chalaz cell involv form endosperm variat recogn within subtyp posit wall tetrad triad format cellular endosperm number nuclei chalaz cell helobi endosperm type embryogenesi possibl compar subtyp even variat cellular endosperm type compar analysi flower plant trait contribut micropylar chalaz cell deriv endosperm format pattern primari cell divis form tetrad consid togeth two subtyp two variat possibl consid helobi endosperm
|
D019684
|
T002
|
36,301,431
|
lichen polar desert northern tip novaya zemlya archipelago polar desert novaya zemlya archipelago analysi depend distribut lichen altitud sea level exposur cardin direct granulometr composit soil morphometr paramet structur soil cover valu bryophyt total cover cushion form plant lichen carri base sampl plot nine lichenocenotyp lichen communiti form specif type habitat identifi shown increas height transit zonal orozon posit cover number lichen speci decreas cover lichen also decreas increas cover moss increas content fraction soil mm speci divers cover lichen increas total lichen speci identifi thamnolia vermiculari l classifi activ nine high activ medium activ rest littl activ inact current pattern lichen distribut landscap far north novaya zemlya larg due histor reason youth landscap recent freed ice cover except high degre mobil cover loos quaternari deposit
|
D008011;D044002
|
T002
|
36,301,430
|
regener dark conifer speci group picea orientali pinacea dri teberda natur reserv western caucasus paper present result survey group orient spruce picea orientali l link declin teberda state natur biospher reserv western caucasus mass dri spruce european spruce bark beetl ip typographus note monodomin spruce forest mix stand abi nordmanniana stev spach fagus orientali lipski dark conifer speci current predomin among regrowth site spruce dri particip decidu tree minor broadleaf speci present small number second layer half sampl plot notic effect abund conifer regener fir regener uniform stabl compar spruce sampl plot number fir regrowth natur decreas matur spruce burst regener height radial growth fir spruce regrowth well densiti distribut area discuss shown year begin mass spruce dri teberda natur reserv area dri group provid reliabl regrowth dark conifer speci come year regener dark conifer speci replenish fir sinc scarc remain generat spruce tree futur provid fire prevent part larg spruce regrowth becom sourc spruce renew fallen dead wood becom suitabl substrat young tree
|
D028222;D028201;D064028;D028202
|
T002
|
36,301,429
|
way forest typolog research siberia articl present brief overview work forest typolog zone siberia conduct forest typolog laboratori institut forest timber ussr academi scienc later sukachev institut forest siberian branch russian academi scienc ecolog phytocoenot line research region approach creation diagnost tabl forest type adopt basi complex field work carri joint forest manag throughout siberia princip featur forest typolog work mountain requir improv system classif unit map forest cover determin diagnost indic signific work develop concept system structur forest cover deep connect concept hierarch structur landscap cover idea biogeocenosi terrestri ecosystem meaning today author speak favor region approach classif forest type close way creation general classif forest ecosystem base climat ordin inform model practic use ecolog phytocenot region classif forest cover substanti creat medium scale map various purpos solv environment manag problem access ecosystem manag forest territori
|
D017753;D065928
|
T070;T082
|
36,301,428
|
divers chrysophycean stomatocyst stepp zone south ural divers chrysophycean stomatocyst studi stepp zone south ural total stomatocyst morphotyp identifi four first time observ russia two morphotyp describ novel morpholog descript scan electron microscop sem imag geograph locat provid stomatocyst high divers chrysophycean stomatocyst point signific develop chrysophyt flora reservoir stepp zone south ural make research relev
|
D044822
|
T080
|
36,301,427
|
mate system seed reproduct gynodioeci geranium asiaticum geraniacea mate system seed reproduct gynodioeci geranium asiaticum serg g bifolium patrin studi four coenopopul western siberia novosibirsk region bisexu flower hermaphrodit individu g asiaticum character longer flower day pistil flower femal individu day due passag male stamin phase begin morphogenesi g asiaticum character strict protandri mate individu g asiaticum occur accord type xenogami autogami complet exclud experi isol individu flower isol pistil bisexu flower dri without fertil experi artifici pollin flower flower pistil flower form fruit wherea flower bisexu flower form fruit signific differ number flower generat shoot femal hermaphrodit individu signific differ found heterosexu individu term number fruit number seed per generat shoot femal individu form time fruit time seed hermaphrodit pistil flower form averag seed per flower bisexu flower seed per flower ie averag femal plant form time seed hermaphrodit found fruit seed form main femal individu hermaphrodit individu produc pollen necessari fertil differ degre sexual differenti g asiaticum geranium sylvaticum l suggest genus geranium transform direct format dioeci
|
D031315;D031314
|
T002
|
36,301,426
|
flower biolog alisma plantago aquatica alismatacea field observ flower alisma plantago aquatica plant carri moscow region russia plantago aquatica flower remain anthet singl light day pm white petal show contrast bicolor pattern uv light pattern probabl serv nectar clue pollin flower visit insect daytim pm coleopteran coccinellida dipteran drosophilida hybotida muscida sepsida syrphida hymenopteran apida observ flower visitor hoverfli syrphida bee apida frequent visitor larg amount plantago aquatica pollen grain found bodi major role pollin consequ assum insect base origin find literatur data plantago aquatica reproduct biolog belgium slovakia czech republ hoverfli identifi stabl effici pollin plantago aquatica various part speci rang bee apida recogn plantago aquatica pollin first time work flower isol experi confirm plantago aquatica self compat plant requir insect effici cross pollin
|
D034902;D034901
|
T002
|
36,301,425
|
anther wall format aeonium balsamiferum ciliatum crassulacea similar featur famili crassulacea differ anther develop structur observ aeonium balsamiferum ciliatum microsporangia round ciliatum elong oval balsamiferum septum microsporangia consequ longer ciliatum extrem short balsamiferum latter pollen spill stomium apic pore phenomenon first discov famili crassulacea mode theca open occur simultan suggest greater special pollin balsamiferum anther outer tapetum singl layer speci cell mononuclear ciliatum binuclear balsamiferum inner tapetum usual singl layer irregular two layer rare case cell increas size factor ciliatum balsamiferum resembl papilloid cell structur latter similar anther structur observ genera aeonium sedum genera anther isobilater transvers section epiconnect four beam connect annular fibrous layer inner side connect lower region fusion anther filament pollen grain structur type tricolpor striat surfac find consist cladist reconstruct put speci polyphylet genus sedum tribe aeoniea sempervivea sedea aeonium balsamiferum ciliatum fall aeonium clade occupi intermedi posit telephium clade sedum kamtschaticum acr clade palmeri
|
D035264;D029627
|
T002
|
36,301,424
|
plant communiti pine forest pinus kochiana pinacea dagestan plant communiti dagestan pine forest compris vascular plant speci examin base materi field studi perform taxonom biomorpholog florocoenot geograph characterist plant communiti show boreal mediterranean natur mesotroph eutroph plant predomin term soil fertil mesophyt mesoxerophyt term soil water avail speci differ altitudin belt includ forest meadow mountain stepp belt observ plant communiti pine forest plant communiti includ speci list red book russian feder republ dagestan relict speci endem
|
D028223;D028201
|
T002
|
36,301,423
|
first experi keep pogonophoran annelida siboglinida laboratori condit articl describ paramet maintain gutless symbiotroph annelid siboglinum fiordicum laboratori condit outsid marin environ day
|
D000845;D011077
|
T204
|
36,301,422
|
matern methyl enrich diet increas dopaminerg tone mesolimb brain system adult offspr wagrij rat aim studi find whether matern methyl enrich diet affect content monoamin metabolit brain structur adult wagrij offspr shown first time matern methyl enrich diet cholin betain folic acid vitamin b l methionin zink perinat period increas dopaminerg tone mesolimb brain system adult offspr wagrij rat accompani suppress symptom genet absenc epilepsi comorbid depress result suggest matern methyl enrich diet perinat period may serv new therapeut strategi prevent develop hypofunct mesolimb dopaminerg brain system associ genet absenc epilepsi comorbid depress offspr
|
D004832
|
T047
|
36,301,421
|
compar studi plutonium radiocaesium content muscl fish yenisey river work report first data content plutonium pu muscl tissu northern pike esox lucius siberian dace leiciscus baicalensi inhabit middl reach yenisey river vicin radioact discharg site increas content pu radiocaesium cs pike muscl follow increas volum control discharg radionuclid yenisey content pu muscl pike mbqkg dri weight dace mbqkg dri weight yenisey fall within rang valu obtain author ichthyofauna water bodi contamin radioact discharg nuclear power plant spent nuclear fuel process plant ratio activ concentr pu cs fish muscl compar similar ratio hydrobiont indic signific lower bioavail plutonium fish obtain preliminari result make possibl consid northern pike prospect indic biolog avail plutonium yenisey dace
|
D011005;D014875
|
T131;T196
|
36,301,420
|
role recombin glycodelin differenti regulatori lymphocyt effect recombin glycodelin gda number regulatori lymphocyt treg cultur activ cd lymphocyt investig simultan assess prolif status cell recombin gda e coli hek cell use studi concentr gml found low concentr gml recombin gda bacteri origin reduc number prolifer cd lymphocyt well number treg cd cd high cd low experiment system vitro
|
D050378;D053699
|
T116;T025;T192
|
36,301,419
|
restructur optokinet reflex metamorphosi pelob fuscus laur restructur gaze stabil system pelob fuscus investig quantit analysi optomotor respons use video imag gaze stabil import compon system neural mechan visual depth percept shown optomotor respons aquat tadpol p fuscus similar fish movement anim direct visual background movement eye nystagmus consist fast slow phase metamorphosi transit aquat terrestri lifestyl froglet p fuscus respond movement visual background eye head movement one year metamorphosi p fuscus respond movement visual background adult anura head movement slow fast phase eye movement absent possibl caus loss activ eye movement anura amphibian process evolut discuss
|
D005133;D012018
|
T039;T042
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.